Our data introduce the novel concept that by targeting the tumor cell and macrophage molecular interactions, PEDF could enhance the tumoricidal activity of macrophages therefore extending the therapeutic role of PEDF in PCa. The gene discussed is SERPINF1; the disease is posterior cortical atrophy.